Forecast
| Buy |
Â
0 |
| Hold |
Â
0 |
| Sell |
Â
1 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Spire Healthcare accepts takeover offer worth ÂŁ1.03 billion
Spire Healthcare agreed to a takeover offer from a consortium that includes funds managed by Toscafund, Three Hills and Ares. Shareholders will receive 250 pence per share in cash, valuing the equity at around £1.03 billion. The stock then rose by more than 3% to 245.5 pence, reaching a one-year high. » More on de.investing.com
Takeover deadline for Spire Healthcare by Toscafund extended by one day
Toscafund has extended the deadline to submit a binding offer for Spire Healthcare to Friday at 17:00 London time in order to finalise financing documents. The potential cash offer amounts to 250 pence per share; due diligence is complete and the transaction documentation is nearly final. Toscafund may reduce the offer under certain conditions, and there is no certainty that a binding offer will actually be made. » More on de.investing.com
Spire Healthcare: takeover deadline for Toscafund extended by one day to 4 September
The board of Spire Healthcare said the deadline for a binding takeover offer from Toscafund Asset Management has been extended by one day to 4 September 2026. Toscafund announced a cash offer of 250 pence per share in May and confirmed that due diligence is complete, but still requires financing documentation and the final transaction documents. The offer remains subject to customary conditions, Toscafund reserves the right in certain circumstances to reduce the offer, and there is no certainty that a binding offer will actually be made. » More on de.investing.com
Spire Healthcare extends takeover deadline for offer from Toscafund to 21 August
Spire Healthcare said the deadline for a binding takeover offer from Toscafund has been extended to 21 August 2026. Toscafund has submitted a revised, non-binding offer of 250 pence per share in cash with an option for unlisted rollover shares and has largely completed its due diligence. The extension is intended to enable completion of the financing arrangements; a binding offer remains subject to usual conditions and is not certain. » More on de.investing.com
Debbie White to succeed Sir Ian Cheshire as chair of Spire Healthcare
Spire Healthcare said Sir Ian Cheshire will resign as chair on 30 September 2026. Debbie White, an independent non‑executive director since February 2023 and senior independent director since May 2023, will take on the role of designated chair with immediate effect and will assume the chair after Cheshire’s resignation. Sir Ian will be available in an advisory capacity during his six‑month notice period; Natalie Ceeney will take on the role of senior independent director. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsIn 2026, Spire Healthcare Group has already paid €0.0173 in dividends. The last payout was in June.
Financials
In the last quarter, Spire Healthcare Group had revenue of €920.17M and net profit of -€13.7M
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 920.17M | - |
| Gross profit | 343.83M | - |
| Net profit | -13.7M | - |
| EBITDA | 130.71M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.19B |
Number of shares | 400.6M |
52-week high/low | €2.99 - €1.68 |
Dividend yield | 0.58% |
Dividends TTM | €0.0173 |
Beta | 0.87 |
P/E ratio | -526.60 |
PEG ratio | 4.78 |
P/B ratio | 1.37 |
P/S ratio | 0.63 |
Company profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
| Name | Spire Healthcare Group |
| CEO | Justin Ash |
| Headquarters | London,
gl United Kingdom |
| Website | |
| IPO | 07/18/2014 |
| Employees | 17,800 |
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | SPI.L |
Frankfurt | S00.F |
DĂĽsseldorf | S00.DU |
London | SPI.L |
MĂĽnchen | S00.MU |